SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

Hodgkin lymphoma (HL) is an uncommon B cell lymphoid malignancy representing approximately 10–15 % of all lymphomas. HL is composed of two distinct disease entities; the more commonly diagnosed classical HL and the rare nodular lymphocyte-predominant HL. An accurate assessment of the stage of diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Rueda Domínguez, A., Alfaro Lizaso, J., de la Cruz Merino, L., Gumá i Padró, J., Quero Blanco, C., Gómez Codina, J., Llanos Muñoz, M., Martinez Banaclocha, N., Rodriguez Abreu, D., Provencio Pulla, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2015
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689754/
https://www.ncbi.nlm.nih.gov/pubmed/26497354
http://dx.doi.org/10.1007/s12094-015-1429-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689754/
https://www.ncbi.nlm.nih.gov/pubmed/26497354
http://dx.doi.org/10.1007/s12094-015-1429-1

Ejemplares similares